Your browser doesn't support javascript.
Profile of specific antibodies to the SARS-CoV-2.
Mou, Danlei; Feng, Huahua; Cao, Ruiyuan; Weng, Xing; Zhao, Lizhe; Yang, Lingling; Jin, Ronghua; Chen, Weijun.
  • Mou D; Beijing Youan Hospital, Capital Medical University, Beijing, PR China.
  • Feng H; BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen, Guangdong, PR China.
  • Cao R; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, PR China.
  • Weng X; BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen, Guangdong, PR China.
  • Zhao L; BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen, Guangdong, PR China.
  • Yang L; BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen, Guangdong, PR China.
  • Jin R; Beijing Youan Hospital, Capital Medical University, Beijing, PR China.
  • Chen W; BGI Education Center, University of Chinese Academy of Sciences, Beishan Industry Area 11, Shenzhen, PR China.
J Med Microbiol ; 70(3)2021 Mar.
Article in English | MEDLINE | ID: covidwho-1140049

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article